Omni Rancho Las Palmas Resort in California

March 6, 2018 – March 8, 2018
Omni Rancho Las Palmas Resort | Rancho Mirage, CA
United States

Register Now ❯

Join us in Rancho Mirage for our 32nd Annual HLA Technical Workshop where you can earn CECs as you learn about advances in transplant diagnostics. This program is led by a faculty of distinguished clinicians and scientists from the world-wide transplant community who will present lectures on the importance of assessing patient risk in transplantation, strategies for knowledge-based HLA antibody identification, and presentations on the role of HLA antibodies and NGS in bone marrow transplantation.

The 2018 Advanced HLA Technical Workshop in Rancho Mirage, California will discuss CAR-T gene therapy as well as the role of HLA and non-HLA antibodies, genotyping, and Hematopoietic Cell Transplantation in organ, blood, and marrow transplantation.

Congratulations to our HLA Case Study winners who will present on March 7.
Select the Day 2 tab to view the full list of winners. Download the program in PDF

Program (select a tab below)


Monday — March 5

1:00 - 5:00 PM
Workshop Registration (Hotel Lobby)
6:00 - 8:00 PM
Welcome Cocktail Reception (Sunrise Terrace)

Tuesday — March 6 | Salon D

8:00 AM
Introduction & Welcome

Ricardo Ordoñez | Thermo Fisher Scientific - Canoga Park, CA

8:15 - 10:00 AM

Antibodies in Transplantation … The Saga Continues!

Nancy Reinsmoen, Ph.D. | Cedars-Sinai Medical Center - Los Angeles, CA

Non-HLA Antibodies – A Stronger Relationship to Organ Transplant?

Annette Jackson, Ph.D. | Johns Hopkins University - Baltimore, MD

Antibodies in Bone Marrow Transplantation

Monzr M. Al Malki, MD | City of Hope – Duarte, CA
10:00 - 10:30 AM 
Coffee Break
10:30 - 12:30 AM

Joint Director/Technical Workshop Session

Laboratory directors from the Unites States will give brief presentations in the areas of HLA and non-HLA antibodies in transplantation, and advances in HLA genotyping.

12:30 - 5:30 PM
Free Afternoon

6:00 - 7:00 PM

Role of Major Histocompatibility Complex Variation in Graft-Versus-Host Disease after Hematopoietic Cell Transplantation

Effie W. Petersdorf, MD | Fred Hutchinson Cancer Research – Seattle, WA

Last Update: 2018 Jan 29

Follow us:  
Facebook LinkedIn Twitter